marijuana stocks news

Form 8-K for LEXARIA CORP.


20-Jan-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing Lexaria test results on nitric oxide filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.Exhibit No. Description

99.1 News Release dated January 20, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Aphria Inc. (APHQF) celebrates the start of the adult-use cannabis market in Canada

Aphria celebrates the start of the adult-use cannabis market in Canada Aphria…

Cara Therapeutics, Inc. (CARA) to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment…

$LXRP Testing and Sales Distribution Update by Lexaria

Laboratory Testing and Sales Distribution Update by Lexaria  Lexaria Corp. (LXRP) (CSE:LXX)…

Verano Holdings Corp. (VRNOF) Prevails in Nielsen Arbitration Dismissing All Claims

Verano Prevails in Nielsen Arbitration Dismissing All Claims Verano Holdings Corp. (CSE:…